Clinical Trial Update: Phase 1b Study of Omega DUROS® in Patients With Chronic Hepatitis C Who Relapsed After Prior Treatment [Phase 1]

View source ↗

Summary

This document reports an update from a Phase 1b study of Omega DUROS in patients with chronic hepatitis C who relapsed after prior treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Omega DUROS

Snippet

Sponsor: Intarcia Therapeutics | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED